1036990-62-1 Usage
Uses
Used in Pharmaceutical Applications:
Imidazo[1,2-a]pyridine-7-carboxamide, 3-iodois utilized as a pharmaceutical agent for its potential inhibitory effects on specific biological processes. Its heterocyclic structure and functional groups contribute to its interaction with biological targets, making it a candidate for the development of new drugs.
Used in Chemical Research:
In the field of chemical research, Imidazo[1,2-a]pyridine-7-carboxamide, 3-iodoserves as a valuable compound for studying the properties and reactions of heterocyclic systems. Its unique structure allows researchers to explore various chemical modifications and potential applications in different areas of chemistry.
Used in Drug Discovery:
Imidazo[1,2-a]pyridine-7-carboxamide, 3-iodois employed as a chemical intermediate in drug discovery efforts. Its ability to be modified and incorporated into more complex molecules makes it a useful building block in the synthesis of novel pharmaceutical compounds with potential therapeutic applications.
Used in Chemical Synthesis Industry:
Within the chemical synthesis industry, Imidazo[1,2-a]pyridine-7-carboxamide, 3-iodois used as a key intermediate in the production of other compounds. Its versatility in chemical reactions and potential for creating new molecules makes it an important component in the development of new chemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 1036990-62-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,6,9,9 and 0 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1036990-62:
(9*1)+(8*0)+(7*3)+(6*6)+(5*9)+(4*9)+(3*0)+(2*6)+(1*2)=161
161 % 10 = 1
So 1036990-62-1 is a valid CAS Registry Number.
1036990-62-1Relevant articles and documents
BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS
-
Page/Page column 109, (2009/05/30)
The invention relates to new bicyclic heterocyclic derivative compounds of formula (I): wherein R1, q, A, B, X1, X2, X3, X4, X5 and R2 are as defined herein, to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS
-
Page/Page column 106, (2009/05/30)
The invention relates to new bicyclic heterocyclic derivative compounds of formula (I): wherein R1, A, X1, X2, X3, X4, X5 and R2 are as defined herein, to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
